These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29416916)

  • 1. Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.
    Papadopoulou K; Murray S; Manousou K; Tikas I; Dervenis C; Sgouros J; Rontogianni D; Lakis S; Bobos M; Poulios C; Pervana S; Lazaridis G; Fountzilas G; Kotoula V
    Am J Cancer Res; 2018; 8(1):2-15. PubMed ID: 29416916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.
    Yu H; Xu Y; Gao W; Li M; He J; Deng X; Xing W
    Front Oncol; 2022; 12():930611. PubMed ID: 36072793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Characterization of
    Mondaca S; Razavi P; Xu C; Offin M; Myers M; Scaltriti M; Hechtman JF; Bradley M; O'Reilly EM; Berger MF; Solit DB; Li BT; Abou-Alfa GK
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32923849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of BRCA-mutated biliary tract cancers.
    Spizzo G; Puccini A; Xiu J; Goldberg RM; Grothey A; Shields AF; Arora SP; Khushman M; Salem ME; Battaglin F; Baca Y; El-Deiry WS; Philip PA; Nassem M; Hall M; Marshall JL; Kocher F; Amann A; Wolf D; Korn WM; Lenz HJ; Seeber A
    ESMO Open; 2020 Jun; 5(3):e000682. PubMed ID: 32576609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers.
    Mody K; Starr J; Saul M; Poorman K; Weinberg BA; Salem ME; VanderWalde A; Shields AF
    J Gastrointest Oncol; 2019 Dec; 10(6):1099-1109. PubMed ID: 31949927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
    Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
    J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.
    Mishra S; Kumari S; Srivastava P; Pandey A; Shukla S; Husain N
    Pathol Res Pract; 2022 Apr; 232():153806. PubMed ID: 35231860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in Japanese extrahepatic biliary tract cancer.
    Noguchi R; Yamaguchi K; Ikenoue T; Terakado Y; Ohta Y; Yamashita N; Kainuma O; Yokoi S; Maru Y; Nagase H; Furukawa Y
    Oncol Lett; 2017 Jul; 14(1):877-884. PubMed ID: 28693246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer.
    Høgdall D; Larsen OF; Linnemann D; Svenstrup Poulsen T; Høgdall EV
    APMIS; 2020 Jan; 128(1):3-9. PubMed ID: 31628675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
    Cybulska P; Paula ADC; Tseng J; Leitao MM; Bashashati A; Huntsman DG; Nazeran TM; Aghajanian C; Abu-Rustum NR; DeLair DF; Shah SP; Weigelt B
    Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yokoyama M; Ohnishi H; Ohtsuka K; Matsushima S; Ohkura Y; Furuse J; Watanabe T; Mori T; Sugiyama M
    Jpn Clin Med; 2016; 7():33-39. PubMed ID: 28008299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients.
    Yang P; Javle M; Pang F; Zhao W; Abdel-Wahab R; Chen X; Meric-Bernstam F; Chen H; Borad MJ; Liu Y; Zou C; Mu S; Xing Y; Wang K; Peng C; Che X
    Hepatobiliary Surg Nutr; 2019 Dec; 8(6):604-614. PubMed ID: 31929987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Approach for the Genetic Analysis of Biliary Tract Cancer Specimens Obtained Through Endoscopic Ultrasound-Guided Fine Needle Aspiration Using Targeted Amplicon Sequencing.
    Hirata K; Kuwatani M; Suda G; Ishikawa M; Sugiura R; Kato S; Kawakubo K; Sakamoto N
    Clin Transl Gastroenterol; 2019 Mar; 10(3):e00022. PubMed ID: 30908307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.
    Terashima T; Umemoto K; Takahashi H; Hosoi H; Takai E; Kondo S; Sakamoto Y; Mitsunaga S; Ohno I; Hashimoto Y; Sasaki M; Ikeda M; Shimada K; Kaneko S; Yachida S; Sugano K; Okusaka T; Morizane C
    Oncotarget; 2019 Oct; 10(57):5949-5957. PubMed ID: 31666926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of BRCA1-related germline mutations in triple-negative breast tumors.
    Kotoula V; Fostira F; Papadopoulou K; Apostolou P; Tsolaki E; Lazaridis G; Manoussou K; Zagouri F; Pectasides D; Vlachos I; Tikas I; Lakis S; Konstantopoulou I; Pentheroudakis G; Gogas H; Papakostas P; Christodoulou C; Bafaloukos D; Razis E; Karavasilis V; Bamias C; Yannoukakos D; Fountzilas G
    Am J Cancer Res; 2017; 7(1):98-114. PubMed ID: 28123851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets.
    Weinberg BA; Xiu J; Lindberg MR; Shields AF; Hwang JJ; Poorman K; Salem ME; Pishvaian MJ; Holcombe RF; Marshall JL; Morse MA
    J Gastrointest Oncol; 2019 Aug; 10(4):652-662. PubMed ID: 31392046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
    Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
    Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.